Abstract
Anorexia nervosa (AN) is a psychiatric disease associated with notable medical complications and increased mortality. Endocrine abnormalities, including hypogonadotropic hypogonadism, hypercortisolemia, growth hormone resistance and sick euthyroid syndrome, mediate the clinical manifestations of this disease. Alterations in anorexigenic and orexigenic appetite-regulating pathways have also been described. Decreases in fat mass result in adipokine abnormalities. Although most of the endocrine changes that occur in AN represent physiologic adaptation to starvation, some persist after recovery and might contribute to susceptibility to AN recurrence. In this Review, we summarize key endocrine alterations in AN, with a particular focus on the profound bone loss that can occur in this disease. Although AN is increasingly prevalent among boys and men, the disorder predominantly affects girls and women who are, therefore, the focus of this Review.
Key Points
-
Anorexia nervosa is associated with characteristic endocrine abnormalities
-
Most of the changes are physiologic adaptations to starvation
-
Some endocrine abnormalities do not normalize with recovery, and may confer a predisposition to disease development and relapse
-
Endocrine pathways mediate the medical complications of anorexia nervosa, including severe osteopenia
-
Weight gain and menstrual recovery are the only known effective, available therapies for bone loss in anorexia nervosa
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hoek HW and van Hoeken D (2003) Review of the prevalence and incidence of eating disorders. Int J Eat Disord 34: 383–396
Keel PK et al. (2003) Predictors of mortality in eating disorders. Arch Gen Psychiatry 60: 179–183
American Psychiatric Association (2000) DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Press
Crisp A and Stonehill E (1971) Relation between aspects of nutritional disturbance and menstrual activity in primary anorexia nervosa. BMJ 3: 149–151
Gendall KA et al. (2006) The psychobiology and diagnostic significance of amenorrhea in patients with anorexia nervosa. Fertil Steril 85: 1531–1535
Jacoangeli F et al. (2006) Amenorrhea after weight recovery in anorexia nervosa: role of body composition and endocrine abnormalities. Eat Weight Disord 11: e20–e26
Misra M et al. (2006) Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res 59: 598–603
Miller KK et al. (2004) Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab 89: 4434–4438
Swenne I (2004) Weight requirements for return of menstruations in teenage girls with eating disorders, weight loss and secondary amenorrhea. Acta Paediatr 93: 1449–1455
Miller KK et al. (2007) Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 92: 1334–1339
Gordon CM et al. (2002) Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatr 141: 64–70
Miller KK et al. (2007) Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry 68: 959–965
Miller KK et al. (2005) Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 90: 1428–1433
Misra M et al. (2004) Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 114: 1574–1583
Grinspoon S et al. (1999) Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 84: 2049–2055
Nussbaum M et al. (1985) Short stature in anorexia nervosa patients. J Adolesc Health Care 6: 453–455
Misra M et al. (2004) Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 89: 4972–4980
Putignano P et al. (2001) Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur J Endocrinol 145: 165–171
dos Santos E et al. (2007) Absence of circadian salivary cortisol rhythm in women with anorexia nervosa. J Pediatr Adolesc Gynecol 2007: 13–18
Gold PW et al. (1986) Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med 314: 1335–1342
Hotta M et al. (1986) The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. J Clin Endocrinol Metab 62: 319–324
Laessle RG et al. (1992) Cortisol levels and vigilance in eating disorder patients. Psychoneuroendocrinology 17: 475–484
Giordano G et al. (2001) Volume measurement with magnetic resonance imaging of hippocampus-amygdala formation in patients with anorexia nervosa. J Endocrinol Invest 24: 510–514
McLoughlin DM et al. (2000) Metabolic abnormalities associated with skeletal myopathy in severe anorexia nervosa. Nutrition 16: 192–196
Grinspoon S et al. (2000) Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 133: 790–794
Grinspoon S et al. (2001) Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr 73: 865–869
Mayer L et al. (2005) Body fat redistribution after weight gain in women with anorexia nervosa. Am J Clin Nutr 81: 1286–1291
Stoving RK et al. (1999) Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J Clin Endocrinol Metab 84: 2056–2063
Misra M et al. (2003) Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 88: 5615–5623
Counts DR et al. (1992) The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 75: 762–767
Støving RK et al. (2007) Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. J Clin Endocrinol Metab 92: 2323–2329
Golden NH et al. (1994) Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa. J Pediatr 125: 655–660
Gianotti L et al. (2000) Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. J Clin Endocrinol Metab 85: 2805–2809
Gianotti L et al. (1999) Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. Biol Psychiatry 45: 334–339
Grinspoon S et al. (2002) Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 87: 2883–2891
Croxson MS and Ibbertson HK (1977) Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa. J Clin Endocrinol Metab 44: 167–174
Leslie RD et al. (1978) Hypothalamo-pituitary-thyroid function in anorexia nervosa: influence of weight gain. BMJ 2: 526–528
Kiyohara K et al. (1989) Decreased thyroidal triiodothyronine secretion in patients with anorexia nervosa: influence of weight recovery. Am J Clin Nutr 50: 767–772
Stoving RK et al. (2001) Evidence of diffuse atrophy of the thyroid gland in patients with anorexia nervosa. Int J Eat Disord 29: 230–235
Onur S et al. (2005) L-tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa during weight gain. Eur J Endocrinol 152: 179–184
Bannai C et al. (1988) Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol Jpn 35: 455–462
Inui A (2001) Eating behavior in anorexia nervosa—an excess of both orexigenic and anorexigenic signaling. Mol Psychiatry 6: 620–624
Grinspoon S et al. (1996) Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 81: 3861–3863
Misra M et al. (2005) Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 289: E373–381
Hebebrand J et al. (1997) Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short- term weight restoration. Mol Psychiatry 2: 330–334
Gendall KA et al. (1999) Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry 46: 292–299
Kopp W et al. (1997) Low leptin levels predict amenorrhea in underweight and eating disordered females. Mol Psychiatry 2: 335–340
Cirmanová V et al. The effect of leptin on bone—an evolving concept of action. Physiol Res, in press
Misra M et al. (2006) Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91: 1027–1033
Pfluger PT et al. (2007) Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab 92: 583–588
Nakahara T et al. (2007) Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 10.1016/j.biopsych.2007.08.005
Otto B et al. (2001) Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145: 669–673
Misra M et al. (2005) Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 289: E347–E356
Vestergaard P et al. (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—A nationwide register study. Int J Eat Disord 32: 301–308
Biller BMK et al. (1989) Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 68: 548–554
Miller KK et al. (2006) Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 91: 2931–2937
Klibanski A et al. (1995) The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80: 898–904
Golden NH et al. (2002) The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 15: 135–143
Munoz M et al. (2002) The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa. Eur J Endocrinol 146: 45–50
Robinson E et al. (2000) Use of hormone replacement therapy to reduce the risk of osteopenia in adolescent girls with anorexia nervosa. J Adolesc Health 26: 343–348
Lawson EA et al. (2007) Hormonal and nutritional effects on cardiovascular risk markers in young women. J Clin Endocrinol Metab 92: 3089–3094
Gordon CM et al. (2002) Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 87: 4935–4941
Bachrach LK et al. (1991) Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 72: 602–606
Dominguez J et al. (2007) Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. Am J Clin Nutr 86: 92–99
Acknowledgements
This work was supported by grants from the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A Klibanski acts as a consultant for Tercica.
EA Lawson declared no competing interests.
Rights and permissions
About this article
Cite this article
Lawson, E., Klibanski, A. Endocrine abnormalities in anorexia nervosa. Nat Rev Endocrinol 4, 407–414 (2008). https://doi.org/10.1038/ncpendmet0872
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0872
This article is cited by
-
Nutritional rickets presenting with developmental regression: a rare presentation of rickets
BMC Pediatrics (2023)
-
Endokrine Veränderungen bei Essstörungen
Journal für Gynäkologische Endokrinologie/Schweiz (2023)
-
Directly measured free 25-hydroxy vitamin D levels show no evidence of vitamin D deficiency in young Swedish women with anorexia nervosa
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2018)
-
A role for intestinal TLR4-driven inflammatory response during activity-based anorexia
Scientific Reports (2016)
-
Anorexia nervosa
Nature Reviews Disease Primers (2015)